NCT05493488View on ClinicalTrials.gov

A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis

PHASE2UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 8, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Tinea Pedis
Interventions
BIOLOGICAL

DBI-001 Gel

Topical application of DBI-001 gel on foot/feet affected with tinea pedis

BIOLOGICAL

DBI-002 Gel

Topical application of DBI-002 gel on foot/feet affected with tinea pedis

BIOLOGICAL

Aqueous Gel

Topical application of Aqueous gel on foot/feet affected with tinea pedis

Trial Locations (2)

97210

Oregon Dermatology and Research, Portland

99202

Premier Clinical Research, Spokane

Sponsors

Lead Sponsor

DermBiont, Inc.
All Listed Sponsors
lead

DermBiont, Inc.

INDUSTRY

NCT05493488 - A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis | Biotech Hunter | Biotech Hunter